WELPANTO-DSR contains Pantoprazole 40 mg (EC) + Domperidone 30 mg (SR), combining effective acid suppression with prokinetic and antiemetic support for selected reflux and digestive disorders. A dependable PCD Pharma Gastro portfolio product.
GERD, acidity and reflux associated with nausea or delayed gastric emptying.
Usually before meals as prescribed.
Take exactly as directed, generally before food. Domperidone should be used at the recommended dose and duration, particularly in patients with cardiac risk factors.
Headache, diarrhea, nausea, abdominal discomfort, dry mouth and dizziness may occur.
WELPANTO-DSR: Pantoprazole suppresses gastric acid secretion through proton-pump inhibition, while Domperidone enhances upper GI motility and helps reduce nausea and reflux-associated symptoms.
